Navigation Links
FFF Enterprises Unveils ‘The 8 Critical Steps to Guaranteed Channel Integrity' at the American Society of Health-System Pharmacists (ASHP) Midyear Meeting in Orlando
Date:12/2/2008

At this year's ASHP midyear meeting, FFF Enterprises, the nation's largest and most trusted distributor of critical-care biopharmaceuticals and vaccines, will unveil its best practices model for supply chain integrity and demonstrate how the company has taken pharmaceutical distribution to a new level. (Booth #1439)

(Vocus) December 2, 2008 -- At this year's ASHP midyear meeting, FFF Enterprises, the nation's largest and most trusted distributor of critical-care biopharmaceuticals and vaccines, will unveil its best practices model for supply chain integrity and demonstrate how the company has taken pharmaceutical distribution to a new level. (Booth #1439)

More than a company that moves product from point A to point B, FFF Enterprises, Inc., the nation’s largest and most trusted distributor of plasma products, vaccines and critical-care biopharmaceuticals, has taken pharmaceutical distribution to a new level. With its "Patients First" philosophy that guides every decision it makes, FFF has made the uncompromising decision to purchase only from the manufacturer and sell only to certified healthcare providers, with 6 additional steps in between, to assure that patients are always the first consideration as products move through its safe channel.

These best practices, which FFF calls The 8 Critical Steps to Guaranteed Channel Integrity™, are crucial to ensuring that patient safety, product efficacy and fair pricing are not compromised anywhere in the supply chain.

Impacting America's pharmaceutical distribution system is precisely what FFF has set as its mission. Having just celebrated its 20th anniversary, and with a perfect safety track record of more than 20 counterfeit-free years, FFF is pleased to unveil The 8 Critical Steps to Guaranteed Channel Integrity at the upcoming ASHP midyear meeting in Orlando, Florida, Dec. 7 – 11, Booth #1439.

"Each step in the 8 steps is critical, it's absolutely essential to the others, to make sure we do not compromise, in any way, patient safety," states Patrick M. Schmidt, chief executive officer, FFF Enterprises. "We are creating a standard for safety and excellence that we hope will continue to have a positive influence on the industry as a whole," he continues.

FFF has clearly set itself apart as an industry leader that goes Beyond Distribution in several ways. Examples include innovative technologies such as the industry's first Verified Electronic Pedigree™ (VEP) system to electronically display the chain of custody for every product that moves through its safe channel, its LotTrack™ service to track products by lot number and provide recall notification to those affected, as well as its MyFluVaccine™ program, which has revolutionized the flu vaccine marketplace.

In addition, FFF provides customers and partners with meaningful communications such as IG Living, the only magazine targeted directly to immune globulin patients and their healthcare providers, its award-winning BioSupply trends e-newsletters, updates, community and flu alerts, and GPO-specific e-newsletters.

FFF's Wow! Customer Care is aptly named, with a responsive, passionate and caring team of knowledgeable professionals that includes customer care representatives, advisors, advocates and a nationwide field team of territory managers to take care of customers needs.

You may visit FFF at ASHP in Orlando at Booth #1439.

About FFF Enterprises, Inc.:
FFF Enterprises, Inc., FFF Enterprises a privately held corporation, is the largest and most trusted distributor of plasma products, vaccines and other biopharmaceuticals in the U.S. Founded in 1988, FFF is celebrating its 20th year with more than a billion dollars in annual sales and a flawless safety track record. FFF's Guaranteed Channel Integrity™ ensures that products are purchased only from the manufacturer and shipped only to healthcare providers, protecting patients and manufacturers from counterfeit risks and pricing irregularities inherent in secondary and gray market channels. FFF’s proprietary technologies, Verified Electronic Pedigree™ and Lot-Track™, provide verification of this secure channel. FFF's MyFluVaccine (www.MyFluVaccine.com) has revolutionized the flu marketplace, offering a dedicated flu vaccine supply, delivered to customers on the date of their choosing, and offering certainty in a volatile market segment. FFF's ability to move rapidly in a dynamically changing marketplace allows the creation of new opportunities for customers through innovative vehicles for distribution.

###

Read the full story at http://www.prweb.com/releases/2008/12/prweb1693544.htm


'/>"/>
Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Nu Skin Enterprises to Hold 2008 Investor Day
2. Nu Skin Enterprises Names Brett Nelson President of Nu Skin Japan
3. Nu Skin Enterprises Opens the Czech Republic
4. CJPS Enterprises to Increase Focus on Automotive Diversification
5. TrailBlazer Health Enterprises Names New President, Chief Operating Officer
6. Nu Skin Enterprises Reports Third-Quarter 2008 Results
7. Nu Skin Enterprises and Toyo Bio-Pharma Enter Agreement for Joint Product Research and Development
8. Nu Skin Enterprises to Announce Second Quarter 2008 Results
9. Medline Receives Force Majeure Notice From Hong Ray Enterprises
10. Nu Skin Enterprises to Present at Oppenheimer Consumer Growth Conference
11. BME (BioMedical Enterprises, Inc.) Announces U.S. Launch of the Barbed OSStaple(TM) (BOSS) Nitinol Implant
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
FFF Enterprises Unveils ‘The 8 Critical Steps to Guaranteed Channel Integrity' at the American Society of Health-System Pharmacists (ASHP) Midyear Meeting in Orlando
(Date:5/2/2016)... ... May 02, 2016 , ... The 2016 World Ultimate & Guts Championship (WUGC) Mixed ... Manhattan College, made the cut. The WUGC is being held in London, England this year ... gold in the men’s division, another gold in the women’s masters division, and a silver ...
(Date:5/2/2016)... Boston, MA (PRWEB) , ... May 02, 2016 , ... ... and tips when trying to conceive. , “If you are ready to ... Dr. Mache Seibel. “My book, HealthChequesTM: Journal Babies is your Personal Conception & ...
(Date:5/2/2016)... , ... May 02, 2016 , ... ... of Permobil, recently completed two groundbreaking studies that determined that the adjustability and ... are critical in the prevention of pressure injuries, which are now referred to ...
(Date:5/2/2016)... ... May 02, 2016 , ... Atlantic Information Services, Inc. (AIS) is pleased to ... Could Transform the Pharma Landscape .” CMS recently proposed a test of alternate payment ... drugs while preserving care provided to beneficiaries. The webinar will review the details of ...
(Date:5/2/2016)... ... May 02, 2016 , ... The Evolve Paddle Board Company- which specializes in ... the outcome of their partnership with Yoloha Yoga- producers of high quality cork yoga ... SUP yoga has seen a dramatic rise in popularity throughout the last few years. ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... MARLTON, N.J. , April 28, 2016   ... solutions, today announced that leading IT market research and ... Player " in the IDC MarketScape: Worldwide Pharmaceutical Track ... March 2016).  The report provides an assessment of the ... pharmaceutical track and trace software market. Logo ...
(Date:4/28/2016)... New market research titled ... report that provides an overview of the Osteoarthritis,s ... identifying new targets and MOAs to produce first-in-class ... in this H1 2016 Osteoarthritis Pipeline report include ... Abiogen Pharma S.p.A., Ablynx NV, Achelios Therapeutics, Inc., ...
(Date:4/27/2016)... PARIS , le 27 Avril 2016 /PRNewswire/ ... chiffre d,affaires a progressé de +5% sur le ... ventes récurrentes de consommables  Croissance de ... Mauna Kea Technologies (Euronext : ... multidisciplinaire d,endomicroscopie confocale laser, annonce aujourd,hui son chiffre ...
Breaking Medicine Technology: